Trellus Management Company’s Iovance Biotherapeutics IOVA Stock Holding History

Trellus Management Company’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-50,000	Closed	-$254K	–	70
2016 Q1	$254K	Sell	50,000 -10,539	-17%	-$57.7K	0.68%	48
2015 Q4	$467K	Hold	60,539	–	–	0.94%	47
2015 Q3	$349K	Buy	60,539 +22,039	+57%	+$172K	0.66%	55
2015 Q2	$353K	Buy	+38,500	New	+$430K	0.51%	65

Other funds holding IOVA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $141M AUM 783.79% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return